CTLA4 and rheumatoid arthritis: This fusion protein combines the extracellular domain of the cytotoxic T lymphocyte-associated antigen-4 with the heavy chain fragment of immunoglobulin G, and it is used to treat several autoimmune inflammatory conditions, including RA, psoriatic arthritis, lupus erythematosus, and inflammatory bowel disease [32].